Status:
UNKNOWN
Heavy Bupivacaine in Peribulbar Block
Lead Sponsor:
Cairo University
Conditions:
Anesthetics, Local
Eligibility:
All Genders
30-80 years
Phase:
PHASE4
Brief Summary
Most of the ophthalmic procedures are performed under local anesthesia as the patient is often elderly and with diseases. This may increase the risk of morbidity and mortality under general anesthesia...
Detailed Description
Peribulbar anesthesia is widely practiced now as a safe local block for cataract eye surgeries. However, the limited duration of these blocks was shown to be the main problem encountered intra-operati...
Eligibility Criteria
Inclusion
- Patients with American Society of Anesthesiology (ASA) I or II.
- 30-80 years old
- Patients scheduled for elective unilateral posterior segment surgeries.
Exclusion
- Patient's refusal.
- orbital deformity
- axial length( \>28 mm )
- increased intraocular pressure, or if they were blind in the contralateral eye, international normalized ratio (INR) \> 1.5
- allergy to local anesthetics, mentally retarded patients
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03312959
Start Date
November 1 2017
End Date
January 31 2018
Last Update
October 18 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Giza Governorate, Egypt, 1234